November 1st, 2025—Imeka, the leading neuroimaging company combining diffusion imaging and AIArtificial Intelligence to map white matterA large network of nerve fibers that communicate between different areas of the brain. microstructureMicrometer-scale tissue features of the brain., today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its new and improved flagship software – ANDIAdvanced Neuro Diagnostic Imaging 2.0, adding brain volumetric analysis to its capabilities. Brain microstructureMicrometer-scale tissue features of the brain. now adds macrostructure in a real one-stop-shop for clinicians.
ImekaTM imaging what matters
ImekaTM and ANDITM are trademarks of ImekaTM Solutions Inc. | © 2026 Imeka